Orange Book product · Brand (NDA)

JADENU

DEFERASIROX

Brand (NDA)NDA 206910TE ABRX NOVARTIS PHARMS CORP

Mar 30, 2015

Approved

Brand (NDA)

Application

TE code

Listed patents

Approval
FDA approval date of this drug product.
Mar 30, 2015
11 yr 5 mo ago
Today
Patent 9283209 expires
Listed drug substance patent expiration.
Nov 21, 2034
in 8 yr 7 mo

Active ingredient

DEFERASIROX

Strength

90MG

Dosage form

TABLET

Route

ORAL

TE code

Application

NDA 206910

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
9283209	Nov 21, 2034	in 8 yr 7 mo	SubstanceProduct